Latest Twitter News | Page 5

Soliris recommended for approval in the EU by CHMP for children and adolescents with refractory generalised myasthenia gravis (gMG)
Taylor Swift: Will Australians experience the same ticketing nightmare as the US?
Football Fans Celebrate On The Sydney Harbour Bridge To Mark 25 Days To Go Until The FIFA Women’s World Cup Australia &…
ESafety demands answers from Twitter about how it’s tackling online hate
Operation Keppel investigation report to be furnished 29 June 2023
RMIT committed to fostering Australia-Spain ties
Real-world evidence highlights the urgent need to act on the growing global burden of chronic kidney disease
Digital News Report Australia 2023: Instagram and TikTok are popular news sources for young Australians
Twitter is refusing to pay Google for cloud services. Here’s why it matters, and what the fallout could be for users
Soliris approved in China for treatment of adults with refractory generalised myasthenia gravis
Frontline health facilities faltering without water, sanitation, hygiene and electricity – WHO, UNICEF new report
Boeing Brings Fuel-Efficient Jets and Defense Capabilities to 2023 Paris Air Show
Capivasertib in combination with Faslodex granted Priority Review in the US for patients with advanced HR-positive breast cancer
AstraZeneca announces agreement with Quell Therapeutics to develop, manufacture and commercialise engineered T-regulatory cell therapies for autoimmune diseases
Update on brazikumab development programme
Roam your own way in Isaac region
Shaw Prize for Patrick Cramer
What are the long-term effects of quitting social media? Almost nobody can log off long enough to find out
Ultomiris approved in Japan for the prevention of relapses in patients with neuromyelitis optica spectrum disorder (NMOSD)
The Monash Uni Pink Rover flies the Aussie flag at the Grand Prix of robotics competitions
What is Bluesky and how’s it different to Twitter?
ACG and AGA Guideline on Chronic Constipation Management is First to Recommend Supplements Magnesium Oxide and Senna as Evidence-Based Treatments
Türk pledges solidarity with LGBTIQ+ activists
Tagrisso plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial
Expert comment: will Twitter’s appointment of a female CEO pave the way for females in big tech?
Big tech is Ignoring Human Cost Behind Rise of ChatGPT
Eurovision 2023: What Australian viewers can expect
Feed me: 4 ways to take control of social media algorithms and get the content you actually want
Ultomiris approved in the EU for adults with neuromyelitis optica spectrum disorder (NMOSD)
Farxiga extended in the US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients
Koselugo approved in China for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
Amcor Recognized as Top Leader in Sustainable Innovations
NEURO-TTRansform Phase III results presented at AAN showed eplontersen demonstrated consistent and sustained improvement in all measures of disease and quality of…
Twitter users feeling hot, hot, hot during heat waves according to study
Imfinzi-based treatment before and after surgery reduced the risk of disease recurrence, progression events or death by 32% in resectable non-small cell…
ECCMID data reinforces AstraZeneca’s commitment to transform protection for the most vulnerable by advancing science in vaccines and immune therapies
Record fine for wagering company Betr over gambling advertisements
Man charged with alleged online procurement of child – Strike Force Trawler
Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi
Teens who trust online information find it less stressful
Calls to regulate AI are growing louder. But how exactly do you regulate a technology like this?
Thumbs down: Why using too many emojis to substitute words can harm your chances online
What are microaggressions? And how can they affect our health?
Ultomiris recommended for approval in the EU by CHMP for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
Jamarra Ugle-Hagan and football’s cycle of racist abuse
License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed
Bank impersonation scams robbing Australians of their life savings
Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) through 66 weeks